Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)

NCT01801449 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

NIH

Sponsor class

Conditions

DIRA

Interventions

DRUG: Rilonacept

Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborators

[object Object]